Binge-Like Exposure to Ethanol Enhances Morphine's Anti-nociception in B6 Mice

Sulie L Chang1,2, Wenfei Huang1,2, Haijun Han1

  • 1Institute of NeuroImmune Pharmacology, South Orange, NJ, United States.

Frontiers in Psychiatry
|February 7, 2019
PubMed

Insights

Binge drinking increases brain inflammation and elevates mu opioid receptor (MOR) expression. This enhances morphine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neuroimmunology

Background:

  • Binge drinking elevates blood ethanol concentration (BEC), triggering brain inflammation and neuroimmune signaling.
  • Morphine abuse is often linked with excessive alcohol consumption, contributing to opioid use disorders (OUDs).
  • Opioid use disorders combined with alcohol increase the risk of fatal opioid overdose.

Purpose of the Study:

  • To investigate if binge drinking potentiates the onset and progression of opioid use disorders.
  • To characterize the time-dependent inflammatory gene expression changes following binge-like ethanol exposure.
  • To examine the impact of binge-like ethanol exposure on morphine's anti-nociceptive effects.

Main Methods:

  • C57BL/6J mice were exposed to binge-like ethanol (EtOH) (5 g/kg, 42% v/v, i.g.).
  • Quantitative real-time PCR (qRT-PCR) was used to measure inflammatory cytokine gene expression (IL-1β, IL-6, IL-18) in the striatum (STr) and nucleus accumbens (NAc).
  • Mu opioid receptor (MOR) expression was analyzed, and behavioral anti-nociception was assessed using the hot-plate test following morphine administration.

Main Results:

  • Binge-like ethanol exposure elevated inflammatory cytokines IL-1β, IL-6, and IL-18 in the STr and NAc.
  • Ethanol exposure upregulated MOR expression in the STr and NAc.
  • Binge-like ethanol exposure shifted the morphine response curve leftward, indicating enhanced anti-nociception.

Conclusions:

  • Binge-like ethanol exposure potentiates morphine's anti-nociceptive effects, mediated by MOR.
  • This potentiation may contribute to the initiation and progression of opioid use disorders.
  • Findings highlight the critical interaction between alcohol and opioids in the context of addiction.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.4K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K